Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen

[1]  J. Trotter,et al.  T cell sensitization to proteolipid protein in myelin basic protein-induced relapsing experimental allergic encephalomyelitis , 1991, Journal of Neuroimmunology.

[2]  E. Sercarz,et al.  The dominant self and the cryptic self: shaping the autoreactive T-cell repertoire. , 1991, Immunology today.

[3]  A. Vandenbark,et al.  T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. , 1991, Science.

[4]  E. Sercarz,et al.  Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides , 1990, The Journal of experimental medicine.

[5]  R. McCarron,et al.  Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis , 1990, Journal of Neuroimmunology.

[6]  N. Sarvetnick,et al.  Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ , 1990, Nature.

[7]  L. Hood,et al.  Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor V beta-specific antibodies , 1990, The Journal of experimental medicine.

[8]  E. Sercarz,et al.  How some T cells escape tolerance induction , 1989, Nature.

[9]  D. Carlo,et al.  Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. , 1989, Science.

[10]  A. Vandenbark,et al.  Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis , 1989, Nature.

[11]  E. Heber-Katz,et al.  The V-region disease hypothesis: evidence from autoimmune encephalomyelitis. , 1989, Immunology today.

[12]  L. Hood,et al.  Autoimmune disease and T-cell immunologic recognition. , 1989, Cold Spring Harbor Symposia on Quantitative Biology.

[13]  E. Heber-Katz,et al.  Protection from experimental allergic encephalomyelitis conferred by a monoclonal antibody directed against a shared idiotype on rat T cell receptors specific for myelin basic protein , 1988, The Journal of experimental medicine.

[14]  J. Rothbard,et al.  Multiple discrete encephalitogenic epitopes of the autoantigen myelin basic protein include a determinant for I-E class II-restricted T cells , 1988, The Journal of experimental medicine.

[15]  L. Hood,et al.  Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy , 1988, Cell.

[16]  D. Mitchell,et al.  Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein , 1988, Journal of Neuroimmunology.

[17]  H. Mcdevitt,et al.  Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention , 1988, Cell.

[18]  L. Perry,et al.  Kinetics and specificity of T and B cell responses in relapsing experimental allergic encephalomyelitis. , 1987, Journal of immunology.

[19]  F. Borek.  Synthetic peptides in biology and medicine: Alitalo, K., P. Partanen and A. Vaheri (eds.), x + 256 pp. Elsevier, Amsterdam, 1985. Dfl. 160.00/$59.25, ISBN 0-444-80753-5 , 1986 .

[20]  J. Frelinger,et al.  Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H-2 and histamine sensitization genes , 1982, The Journal of experimental medicine.

[21]  R. Lechler,et al.  The question as to why major histocompatibility complex (MHC) a antigens are uniquely powerful primary immunogens and in this respect differ from antigens of the minor systems , 2003 .

[22]  I. Cohen,et al.  Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein , 1981, Nature.

[23]  R. Martenson,et al.  Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. , 1972, Preparative biochemistry.